Search

Search Constraints

You searched for: Author/Creator Roberson, Erik D.

Search Results

1. 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Issue 4 (23rd October 2017)

2. [O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE. (1st July 2017)

3. [P2–303]: ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS. (1st July 2017)

4. [P4–189]: SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA. (1st July 2017)

5. A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent. Issue 4 (3rd April 2020)

6. AlphaScreen HTS and Live-Cell Bioluminescence Resonance Energy Transfer (BRET) Assays for Identification of Tau–Fyn SH3 Interaction Inhibitors for Alzheimer Disease. (December 2014)

7. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Issue 1 (8th January 2020)

8. Association of Performance on the Financial Capacity Instrument–Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults. Issue 2 (April 2022)

9. Brain volumetric deficits in MAPT mutation carriers: a multisite study. Issue 1 (28th November 2020)

10. Brain volumetric deficits in MAPT mutation carriers: a multisite study. Issue 1 (28th November 2020)